De novo loss-of-function variants in NSD2 (WHSC1) associate with a subset of Wolf–Hirschhorn syndrome

  1. Erik J. Zmuda1,2
  1. 1The Institute for Genomic Medicine at Nationwide Children's Hospital, Columbus, Ohio 43215, USA;
  2. 2Department of Pathology, The Ohio State University College of Medicine, Columbus, Ohio 43210, USA;
  3. 3Division of Genetic and Genomic Medicine,
  4. 4Center for Cardiovascular Research, Nationwide Children's Hospital, Columbus, Ohio 43205, USA;
  5. 5Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio 43210, USA
  1. Corresponding author: ezmuda{at}counsyl.com

Abstract

Wolf–Hirschhorn syndrome (WHS) is a rare but recurrent microdeletion syndrome associated with hemizygosity of an interstitial segment of Chromosome 4 (4p16.3). Consistent with historical reports in which overlapping deletions defined a minimal critical region in WHS patients, recent reports from exome sequence analysis have provided further evidence that haploinsufficiency of a specific gene within this critical region, NSD2 (WHSC1), is causal for many features of the syndrome. In this report, we describe three unrelated patients with loss-of-function alterations in NSD2 who presented clinically with WHS features including intrauterine growth retardation and global developmental delay. Two of the three patients also had overlapping features of failure to thrive, short stature, constipation, and hypotonia. This series adds additional cases to expand the phenotypic spectrum of WHS and reports novel NSD2 variants.

  • Received February 11, 2019.
  • Accepted May 6, 2019.

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial License, which permits reuse and redistribution, except for commercial purposes, provided that the original author and source are credited.

| Table of Contents